| About the author: |
N. M. Horbal, G. O. Potemkina, I. J. Kril, I. G. Gaiduchok, Y. V. Fedorov, V. V. Chopyak |
| Heading |
EXPERIMENTAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
In this article, the authors propose the results of the investigation of the interferon–alpha synthesis dynamics at the local and systemic levels in patients with recurrent herpes simplex virus, analyzed the effect of different types of therapy on the interferon–alpha synthesis and established the clinical efficacy depending on the therapy received. It was found that patients with mild herpes simplex after antiviral therapy and during follow–up showed normalization of the interferon–alpha level. The results indicate the stabilization of antiviral protection in patients who received antiviral therapy (acyclovir and/or inosine pranobex) and the possible further persistence of the virus in patients treated by acyclovir and/or placebo. The clinical efficacy of antiviral treatment of patients with recurrent herpes simplex virus was established: with a mild course of infection after treatment it was 73.5 %, during follow–up – 85.8 %; with a medium to severe and a severe – after treatment – 64.0 %, during follow–up – 70.4 %. |
| Tags |
herpes simplex virus, interferon¬–alpha, antiviral therapy, interferon refractoriness |
| Bibliography |
- Belikova EA, Ivanova GF. Sovremennyye predstavleniya o herpeticheskoy infektsyi. Lekarstvennyy vestnik. 2015; 3(59): 22–27. [In Russian]
- Vyhovska OV. Herpesvirusni infektsyi u ditey: klasyfikatsiya, klinichni formy, proyavy, sotsialno-medychni aspekty. Dutaychyy likar. 2016; 4(49): 41–51. [in Ukrainian]
- Gyliyk OG, Bulat LM. Osoblyvosti diahnostyky dyfuznykh urazen hepatobiliarnoyi systemy pry herpesvirusniy infektsyi v ditey, shcho zumovlena Epstein-Barr virusom (izolyovana ta u formi mikst infektsyi). Zaporozhye Medical Journal. 2018; 20(4): 503–508. [in Ukrainian]
- Homolyaka IV, Starosyla DB, Zarkova LD. Morfolohichni ta virusologichni kharakterystyky eksperymentalnoyi virusnoyi infektsyi, vyklykanoyi virusom prostogo herpesu 1 typu. Laboratorna diagnostyka. 2012; 2(60): 41–45. [in Ukrainian]
- Isakov VA, Isakov DV. Patogenez i lecheniye sotsialno znachimykh virusnych urogenitalnykh infektsiy (gerpesa i papilomavirusnoy infektsii). Klinicheskaya farmakologiya i terapiya. 2014; 23(1): 6–13. [In Russian]
- Mikhaev OG. Prostyy herpes: patogenez, klinika ta likuvannya. Zdorovya Ukrainy. 2015; 1: 25–35. [in Ukrainian]
- Chopyak VV. Lektsiyi z klinichnoyi imunolohii ta alergologiyi dlya praktychnykh likariv. Lviv: Vydavnytstvo LNMU imeni D.Halytskoho. 2014: 124–148. [in Ukrainian]
- Danastas K, Miranda-Saksena M, Cunningham AL. herpes simplex virus type 1 interactions with the interferon system. International Journal of Molecular Sciences. 2020; 21, 5150.
- Hugh JF, Biswas S. Antiviral drug resistance and helicase–primase inhibitors of herpes simplex virus. Drug Resistance Updates. 2011; 14(1): 45–51.
- Kwiatkowski A, Gallois J, Bilbault N. Herpes encephalitis during natalizumab treatment in multiple sclerosis. Mult Scler. 2012; 18(6): 909–911.
- Noska A, Kyrillos R, Hansen G, Hirigoyen D, Williams DN. The role of antiviral therapy in immunocompromised patients with Herpes Simplex virus meningitis. Clinical Infectious Diseases. 2015; 60(2): 237–242.
- You Y, Wang L, Li Y, Wang Q, Cao S., Tu Y. et al. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. Journal of Dermatology. 2015; 42: 1–6.
|
| Publication of the article |
«World of Medicine and Biology» №2(76), 2021 year, 193-197 pages, index UDK 616. 523- 092.19 - 036 |
| DOI |
10.26724/2079-8334-2021-2-76-193-197 |
